NDC 24208-353 – Alrex

Loteprednol Etabonate 2 mg/mL · Suspension/ Drops · Ophthalmic

Human Prescription Drug

Product NDC24208-353

Product details

Brand name
Alrex
Generic name
Loteprednol etabonate
Labeler
Bausch & Lomb Incorporated
Dosage form
Suspension/ Drops
Route
Ophthalmic
Marketing category
NDA · NDA020803
Marketed since
March 9, 1998
Listing expires
December 31, 2026
Pharmacologic class
Corticosteroid

Active ingredients

Uses, dosage, side effects and warnings for Alrex →

Package NDC codes (3)

Package NDCDescriptionSince
24208-353-01 sample1 BOTTLE, DROPPER in 1 CARTON (24208-353-01) / 1 mL in 1 BOTTLE, DROPPERMar 9, 1998
24208-353-051 BOTTLE, DROPPER in 1 CARTON (24208-353-05) / 5 mL in 1 BOTTLE, DROPPERMar 9, 1998
24208-353-101 BOTTLE, DROPPER in 1 CARTON (24208-353-10) / 10 mL in 1 BOTTLE, DROPPERMar 9, 1998